A simple synthetic pathway to obtain glycosilated β-diketo derivatives is proposed. These compounds show a good iron(III) affinity therefore we may suggest the use of their Fe3+-complexes as oral iron supplements in the treatment of anaemia. The glycosilated compounds (6-GlcH, 6-GlcOH and 6-GlcOCH3) are characterized by means of spectroscopic (UV, 1H and 13C NMR) and potentiometric techniques; they have a good water solubility, are kinetically stable in physiological condition (t1/2 > 100 h) and show a low cytotoxicity also in high concentrations (IC50 > 400 μM). They are able to bind Fe3+ ion in acid condition (pH ∼ 2) forming complex species thermodynamically more stable than those of other ligands commonly used in the treatment of iron deficiency. The iron complexes show also a good kinetic stability both in acidic and physiological pH and have a good lypophilicity (log P > -0.7) that suggests an efficient gastrointestinal absorption in view of their possible use in oral therapy. In addition they demonstrate a poor affinity for competitive biological metal ion such as Ca2+, and in particular 6-GlcOCH3 is able to inhibit lipid peroxidation. © 2008 Elsevier Masson SAS. All rights reserved.

Arezzini, B., Ferrali, M., A., F.E., Lazzari, S., B., M.G., Spagnolo, F., et al. (2008). Synthesis, chemical and biological study on new Fe3+-glycosilated β-diketo complexes for the treatment of iron deficiency. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 43(11), 2549-2556 [10.1016/j.ejmech.2008.02.045].

Synthesis, chemical and biological study on new Fe3+-glycosilated β-diketo complexes for the treatment of iron deficiency

FERRALI, MARCO;
2008-01-01

Abstract

A simple synthetic pathway to obtain glycosilated β-diketo derivatives is proposed. These compounds show a good iron(III) affinity therefore we may suggest the use of their Fe3+-complexes as oral iron supplements in the treatment of anaemia. The glycosilated compounds (6-GlcH, 6-GlcOH and 6-GlcOCH3) are characterized by means of spectroscopic (UV, 1H and 13C NMR) and potentiometric techniques; they have a good water solubility, are kinetically stable in physiological condition (t1/2 > 100 h) and show a low cytotoxicity also in high concentrations (IC50 > 400 μM). They are able to bind Fe3+ ion in acid condition (pH ∼ 2) forming complex species thermodynamically more stable than those of other ligands commonly used in the treatment of iron deficiency. The iron complexes show also a good kinetic stability both in acidic and physiological pH and have a good lypophilicity (log P > -0.7) that suggests an efficient gastrointestinal absorption in view of their possible use in oral therapy. In addition they demonstrate a poor affinity for competitive biological metal ion such as Ca2+, and in particular 6-GlcOCH3 is able to inhibit lipid peroxidation. © 2008 Elsevier Masson SAS. All rights reserved.
2008
Arezzini, B., Ferrali, M., A., F.E., Lazzari, S., B., M.G., Spagnolo, F., et al. (2008). Synthesis, chemical and biological study on new Fe3+-glycosilated β-diketo complexes for the treatment of iron deficiency. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 43(11), 2549-2556 [10.1016/j.ejmech.2008.02.045].
File in questo prodotto:
File Dimensione Formato  
Synthesis, chemical and biological studies on new Fe3plus-Arezzini-2008.pdf

non disponibili

Descrizione: Articolo
Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 625.89 kB
Formato Adobe PDF
625.89 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/399737